Additionally, until the approval of the new drugs acting upon the calcitonin gene‐related peptide (CGRP) pathway, CM complicated with MOH was the most refractory form of headache, and a painkiller withdrawal was necessary before a new preventive treatment could be started (Nielsen et al., 2019). Here, CALCA is linked to cutaneous mastocytosis.